Diploma PLC (LON:DPLM) Stock Has Average Price Target of GBX 7,400 According to Brokerages

Shares of Diploma PLC (LON:DPLM) have been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is GBX 7,400.

DPLM has been the subject of several research analyst reports. Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 7,400 price target on shares of Diploma in a research report on Tuesday, September 8th. Berenberg Bank restated a “buy” rating and set a GBX 9,000 price objective on shares of Diploma in a report on Monday, July 20th. Finally, JPMorgan Chase & Co. increased their target price on Diploma from GBX 5,760 to GBX 8,250 and gave the stock an “overweight” rating in a research report on Monday, August 24th.

Diploma Price Performance

DPLM stock opened at GBX 7,890 on Tuesday. The company has a quick ratio of 0.80, a current ratio of 2.06 and a debt-to-equity ratio of 47.65. The stock has a market capitalization of £10.58 billion, a price-to-earnings ratio of 56.04, a price-to-earnings-growth ratio of 2.82 and a beta of 0.92. The stock’s fifty day simple moving average is GBX 7,446.38 and its 200-day simple moving average is GBX 7,132.61. Diploma has a 52-week low of GBX 4,970 and a 52-week high of GBX 7,980.

Insider Buying and Selling at Diploma

In other news, insider Katie Bickerstaffe  bought 246 shares of the firm’s stock in a transaction dated Wednesday, September 23rd. The stock was acquired at an average price of GBX 7,696 per share, for a total transaction of £18,932.16. 1.14% of the stock is owned by corporate insiders.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.